Analyst Ratings for ZIOPHARM Oncology (ZIOP)
ZIOP Rating Summary
ZIOP Price Target Summary
- Highest: $9.00 (Canaccord Genuity)
- Lowest: $1.00 (BMO Capital)
- Average: $5.50
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$5.50 (+207.3%)
Avg. $ Target:
$5.50 (+207.3%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/27/2013 | Brinson Patrick | Downgrade | Market Perform (Market Outperform) |
1.50 (7.00) |
1.82 | 1.79 | -1.65% | Details |
| 3/27/2013 | JPMorgan | Downgrade | Neutral (Overweight) |
N/A (N/A) |
1.82 | 1.79 | -1.65% | Details |
| 3/26/2013 | JMP Securities | Downgrade | Market Perform (Market Outperform) |
N/A (N/A) |
5.13 | 1.79 | -65.11% | Details |
| 3/26/2013 | BMO Capital | Downgrade | Underperform (Market Perform) |
1.00 (6.00) |
5.13 | 1.79 | -65.11% | Details |
| 1/18/2013 | Piper Jaffray | New Coverage | Neutral (N/A) |
5.00 (N/A) |
4.17 | 1.79 | -57.07% | Details |
| 12/12/2012 | Jefferies | Downgrade | Hold (Buy) |
4.00 (7.00) |
4.44 | 1.79 | -59.68% | Details |
| 3/26/2012 | Canaccord Genuity | New Coverage | Buy (N/A) |
9.00 (N/A) |
5.11 | 1.79 | -64.97% | Details |
| 12/15/2011 | Global Hunter Securities | New Coverage | Buy (N/A) |
9.00 (N/A) |
4.23 | 1.79 | -57.68% | Details |
| 11/22/2011 | Collins Stewart | New Coverage | Buy (N/A) |
9.00 (N/A) |
4.31 | 1.79 | -58.47% | Details |
| 2/23/2011 | Barclays » Updated 3/2/2011 |
New Coverage | Overweight (N/A) |
N/A (N/A) |
5.76 | 1.79 | -68.92% | Details |
